YDESW YD BIO LTD revenue, earnings and financials
For the fiscal year ended December 2025 revenue was $597K, up 16.9% on the year before.
YDESW annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $597K, gross profit $167K, operating income −$5.27M, net income −$8.31M (margin -1392.6%), EPS −$0.12
- Fiscal year ended Dec 2024: revenue $510K, gross profit $155K, operating income −$1.46M, net income −$1.41M (margin -276.6%), EPS −$0.02
- Fiscal year ended Dec 2023: revenue $350K, gross profit $153K, operating income −$9.85K, net income $13.6K (margin 3.9%), EPS $0.00
YDESW cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$6.60M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$1.22M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$55.7K, share buybacks n/a
YDESW balance sheet
- Dec 31, 2025: cash $6.01M, total assets $13.8M, total liabilities $16.6M, shareholders' equity −$2.86M
- Dec 31, 2024: cash $3.13M, total assets $6.86M, total liabilities $274K, shareholders' equity $6.59M
What is YDESW's revenue?
YD BIO LTD reported $597K of revenue for the fiscal year ended December 2025.
Is YDESW profitable?
No. YD BIO LTD lost $8.31M in its latest fiscal year.